BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 33838255)

  • 1. Octanoic acid suppresses harmaline-induced tremor in mouse model of essential tremor.
    Nahab FB; Handforth A; Brown T; Shin C; Quesada A; Dong C; Haubenberger D; Hallett M
    Neurotherapeutics; 2012 Jul; 9(3):635-8. PubMed ID: 22454323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol and 1,25-dihydroxyvitamin D decrease Lingo-1 levels, and improve behavior in harmaline-induced Essential tremor, suggesting potential therapeutic benefits.
    Pirmoradi Z; Nakhaie M; Ranjbar H; Kalantar-Neyestanaki D; Kohlmeier KA; Asadi-Shekaari M; Hassanshahi A; Shabani M
    Sci Rep; 2024 Apr; 14(1):9864. PubMed ID: 38684734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pramipexole Reduces zif-268 mRNA Expression in Brain Structures involved in the Generation of Harmaline-Induced Tremor.
    Kosmowska B; Ossowska K; Wardas J
    Neurochem Res; 2020 Jul; 45(7):1518-1525. PubMed ID: 32172399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harmaline toxicity on dorsal striatal neurons and its role in tremor.
    Zhan X; Do LV; Zou L; Zhan RS; Jones M; Nawaz S; Manaye K
    Neurotoxicology; 2023 Dec; 99():152-161. PubMed ID: 37838252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebellar α6GABA
    Huang YH; Lee MT; Hsueh HY; Knutson DE; Cook J; Mihovilovic MD; Sieghart W; Chiou LC
    Neurotherapeutics; 2023 Mar; 20(2):399-418. PubMed ID: 36696034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous agmatine has neuroprotective effects against restraint-induced structural changes in the rat brain.
    Zhu MY; Wang WP; Cai ZW; Regunathan S; Ordway G
    Eur J Neurosci; 2008 Mar; 27(6):1320-32. PubMed ID: 18364017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Role for GABA
    Handforth A; Singh RP; Kosoyan HP; Kadam PA
    Tremor Other Hyperkinet Mov (N Y); 2024; 14():20. PubMed ID: 38681506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label, single-dose, crossover study of the pharmacokinetics and metabolism of two oral formulations of 1-octanol in patients with essential tremor.
    Nahab FB; Wittevrongel L; Ippolito D; Toro C; Grimes GJ; Starling J; Potti G; Haubenberger D; Bowen D; Buchwald P; Dong C; Kalowitz D; Hallett M
    Neurotherapeutics; 2011 Oct; 8(4):753-62. PubMed ID: 21594724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Pathophysiology and Treatment of Essential Tremor: The Role of Adenosine and Dopamine Receptors in Animal Models.
    Kosmowska B; Wardas J
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Harmaline-induced Tremor in a Swine Model.
    Lee J; Kim I; Lee J; Knight E; Cheng L; Kang SI; Jang DP; Chang SY
    Tremor Other Hyperkinet Mov (N Y); 2018; 8():532. PubMed ID: 29686939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Olivary Hypothesis of Essential Tremor: Time to Lay this Model to Rest?
    Louis ED; Lenka A
    Tremor Other Hyperkinet Mov (N Y); 2017; 7():473. PubMed ID: 28966877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABA
    Kuo SH
    Neurotherapeutics; 2023 Mar; 20(2):372-374. PubMed ID: 36765025
    [No Abstract]   [Full Text] [Related]  

  • 13. Loss of NCB5OR in the cerebellum disturbs iron pathways, potentiates behavioral abnormalities, and exacerbates harmaline-induced tremor in mice.
    Stroh MA; Winter MK; Swerdlow RH; McCarson KE; Zhu H
    Metab Brain Dis; 2016 Aug; 31(4):951-64. PubMed ID: 27188291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database.
    Antonazzo IC; Rozza D; Conti S; Fornari C; Cortesi PA; Eteve-Pitsaer C; Paris C; Gantzer L; Valentine D; Mantovani LG; Mazzaglia G
    Eur J Neurol; 2024 Jan; 31(1):e16064. PubMed ID: 37738526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Objective response to ethanol in essential tremor: results from a standardized ethanol challenge study.
    McGurrin P; Norato G; Thompson-Westra J; McCrossin G; Lines E; Lungu C; Pandey S; Tinaz S; Voller B; Ramchandani V; Hallett M; Haubenberger D
    Ann Clin Transl Neurol; 2024 Jan; 11(1):156-168. PubMed ID: 38087917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of essential tremor with long-chain alcohols: still experimental or ready for prime time?
    Haubenberger D; Nahab FB; Voller B; Hallett M
    Tremor Other Hyperkinet Mov (N Y); 2014; 4():. PubMed ID: 24587968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The time interval between injection of nicotine and tremor initiation: a new index for evaluating nicotine efficacy in rodents.
    Esmaeeli Dehaj H; Maleki Dehnavi S; Zahedi Nejad M; Akbarzadeh Kolahi S; Abdolghaffari AH; Khalili A; Mazloom R
    Toxicol Mech Methods; 2024 May; 34(4):408-412. PubMed ID: 38092698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agmatine has beneficial effect on harmaline-induced essential tremor in rat.
    Akman Ö; Utkan T; Arıcıoğlu F; Güllü K; Ateş N; Karson A
    Neurosci Lett; 2021 May; 753():135881. PubMed ID: 33838255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of sphingosine-1-phosphate receptor ameliorates harmaline-induced essential tremor in rat.
    Dahmardeh N; Asadi-Shekaari M; Arjmand S; Kalantaripour T; Basiri M; Shabani M
    Neurosci Lett; 2017 Jul; 653():376-381. PubMed ID: 28627375
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.